ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Health

Researchers suggest new way of treating spinal cord injury

The therapy of spinal cord injury has showed a great deal of promise thanks to a novel new substance created at the University of Limerick in Ireland.

ANI Dec 05, 2022 04:39 IST googleads

Representative Image

Washington [US], December 5 (ANI): An innovative new substance created at the University of Limerick in Ireland has shown a great deal of potential in the treatment of spinal cord injury.
The research conducted at UL's Bernal Institute -- published in the journal Biomaterials Research -- has made exciting progress in the field of spinal cord tissue repair.
New hybrid biomaterials developed at UL in the form of nanoparticles and building on existing practice in the tissue engineering field, were successfully synthesised to promote repair and regeneration following spinal cord injury, according to the researchers.
The UL team led by Professor Maurice N Collins, Associate Professor, School of Engineering at UL and lead author Aleksandra Serafin, a PhD candidate at UL, used a new kind of scaffolding material and a unique new electrically conducting polymer composite to promote new tissue growth and generation that could advance the treatment of spinal cord injury.
"Spinal Cord Injury remains one of the most debilitating traumatic injuries a person can sustain during their lifetime, affecting every aspect of the person's life," explained Professor Collins.
"The debilitating disorder results in paralysis below the level of injury and, in the US alone, the annual healthcare costs for SCI patient care are $9.7 billion. As there is currently no widely available treatment, continuous research into this field is crucial to find a treatment to improve the patient's quality of life, with the research field turning towards tissue engineering for novel treatment strategies.
"The field of tissue engineering aims to solve the global problem of shortages of donated organs and tissues, in which a new trend has emerged in the form of conductive biomaterials. Cells in the body are affected by electrical stimulation, especially cells of a conductive nature such as cardiac or nerve cells," Professor Collins explained.
The research team describe a growing interest in the use of electroconductive tissue engineered scaffolds that has emerged due to the improved cell growth and proliferation when cells are exposed to a conductive scaffold.
"Raising the conductivity of biomaterials to develop such treatment strategies typically centres on the addition of conductive components such as carbon nanotubes or conductive polymers such as PEDOT:PSS, which is a commercially available conductive polymer that has been used to date in the tissue engineering field," explained lead author Aleksandra Serafin, a PhD candidate in the Bernal and at UL's Faculty of Science and Engineering.
"Unfortunately, severe limitations persist when using the PEDOT:PSS polymer in biomedical applications. The polymer relies on the PSS component to allow it to be water soluble, but when this material is implanted in the body, it displays poor biocompatibility.
"This means that upon exposure to this polymer, the body has potential toxic or immunological responses, which are not ideal in an already damaged tissue which we are trying to regenerate. This severely limits which hydrogel components can be successfully incorporated to create conductive scaffolds," she added.
Novel PEDOT nanoparticles (NPs) were developed in the study to overcome this limitation. Synthesis of conductive PEDOT NPs allows for the tailored modification of the surface of the NPs to achieve desired cell response and increasing the variability of which hydrogel components can be incorporated, without the required presence of PSS for water solubility.
In this work, hybrid biomaterials composed of gelatin and immunomodulatory hyaluronic acid, a material which Professor Collins has developed over many years at UL, was combined with the developed novel PEDOT NPs to create biocompatible electroconductive scaffolds for targeted spinal cord injury repair.
A complete study of the structure, property, and function relationships of these precisely designed scaffolds for optimised performance at the site of injury was carried out, including in-vivo research with rat spinal cord injury models, which was undertaken by Ms Serafin during a Fulbright research exchange to the University of California San Diego Neuroscience Department, who were a partner on the project.
"The introduction of the PEDOT NPs into the biomaterial increased the conductivity of samples. In addition, the mechanical properties of implanted materials should mimic the tissue of interest in tissue engineered strategies, with the developed PEDOT NP scaffolds matching the mechanical values of the native spinal cord," explained the researchers.
Biological response to the developed PEDOT NP scaffolds were studied with stem cells in-vitro and in animal models of spinal cord injury in-vivo. Excellent stem cell attachment and growth on the scaffolds was observed, they reported.
Testing showed greater axonal cell migration towards the site of spinal cord injury, into which the PEDOT NP scaffold was implanted, as well as lower levels of scarring and inflammation than in the injury model which had no scaffold, according to the study.
Overall, these results show the potential of these materials for spinal cord repair, say the research team.
''The impact that spinal cord injury has a on a patient's life is not only physical, but also psychological, since it can severely affect the patient's mental health, resulting in increased incidence of depression, stress, or anxiety," explained Ms Serafin.
"Treating spinal injuries will therefore not only allow for the patient to walk or move again but will allow them to live their lives to their full potential, which makes projects such as this one so vital to the research and medical communities. In addition, the overall societal impact in providing an effective treatment to spinal cord injuries will lead to a reduction in health care costs associated with treating patients.
"These results offer encouraging prospects for patients and further research into this area is planned.
"Studies have shown that the excitability threshold of motor neurons on the distal end of a spinal cord injury tends to be higher. A future project will further improve the scaffold design and create conductivity gradients in the scaffold, with the conductivity increasing towards the distal end of the lesion to further stimulate neurons to regenerate," she added. (ANI)

Get the App

What to Read Next

Health

Scientists solve a major roadblock in cancer cell therapy: Study 

Scientists solve a major roadblock in cancer cell therapy: Study 

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system's coordinators, helping other immune cells fight longer and harder.

Read More
Health

Scientists find hidden synapse hotspots in the teen brain: Study

Scientists find hidden synapse hotspots in the teen brain: Study

The scientists have discovered that the adolescent brain does more than prune old connections. During the teen years, it actively builds dense new clusters of synapses in specific parts of neurons.

Read More
Health

Scientists found a way to help ageing guts heal themselves

Scientists found a way to help ageing guts heal themselves

Researchers have discovered a way to help aging intestines heal themselves using CAR T-cell therapy. By targeting senescent cells that build up over time, the treatment boosted gut regeneration, reduced inflammation, and improved nutrient absorption in mice.

Read More
Health

Iimmune cells use surprising trick to heal muscle faster: Study

Iimmune cells use surprising trick to heal muscle faster: Study

A research team has found that specific immune cells can connect with muscle fibres in a lightning-fast, neuron-like way to promote healing.

Read More
Health

Stem cell therapy helps AMD patients see again

Stem cell therapy helps AMD patients see again

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely affected patients.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.